Veracyte, Inc. (VCYT)
42.92
+0.04
(+0.09%)
USD |
NASDAQ |
Dec 30, 09:45
Veracyte Market Cap: 3.393B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Thermo Fisher Scientific, Inc. | 219.01B |
| FONAR Corp. | 118.59M |
| XWELL, Inc. | 3.114M |
| ProPhase Labs, Inc. | 1.801M |
| Insight Molecular Diagnostics, Inc. | 191.48M |
Market Cap Related Metrics
| PE Ratio | 113.07 |
| PS Ratio | 6.892 |
| Price to Book Value | 2.698 |
| Price to Free Cash Flow | 34.75 |
| Price | 42.92 |
| Earnings Yield | 0.88% |
| Operating PE Ratio | 69.04 |
| Normalized PE Ratio | 72.73 |